Gemina Laboratories Ltd.
GLAB
Rank in Stocks
#35677
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Share Price
$0.04377166
Last synced: 2026-02-05
Market Cap
$3.35M
Change (1 day)
-0.30%
Change (1 year)
-81.04%
Country
CA
Trade Gemina Laboratories Ltd. (GLAB)
Category
Healthcare
Stock price history for Gemina Laboratories Ltd. (GLAB)
Highest end of day price: $0.05 on 2026-10-01
Lowest end of day price: $0.42 on 2022-03-01
Lowest end of day price: $0.42 on 2022-03-01
Stock price history of Gemina Laboratories Ltd. from 2022 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -16.83% |
| 2025 | -80.23% |
| 2024 | 53.58% |
| 2023 | 50.57% |
| 2022 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $525.30 | 23.23% |
US
|
|
| $252.60 | 818.88% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $888.91 | 6.49% |
NL
|
|
| $752.87 | 7.40% |
CH
|
